Related Experiment Video
Updated: Jun 21, 2026
08:33
Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
Protein SUMOylation in neuropathological conditions
Dina B Anderson1, Kevin A Wilkinson, Jeremy M Henley
1Medical Research Council Centre for Synaptic Plasticity, University of Bristol, Bristol BS8 1TD, UK.
Drug News & Perspectives
|July 18, 2009
Summary
Small ubiquitin-related modifier (SUMO) proteins regulate nuclear processes and neuronal function. SUMOylation pathway dysfunction is linked to neurodegenerative diseases, suggesting it as a potential drug target.
Area of Science:
- Biochemistry
- Cell Biology
- Neuroscience
Background:
- Small ubiquitin-related modifier (SUMO) proteins are key post-translational modifiers.
- SUMOylation regulates essential nuclear processes and cellular viability.
- Emerging evidence highlights SUMOylation's role in neuronal integrity and synaptic function.
Purpose of the Study:
- To review current knowledge of the SUMO pathway.
- To discuss the role of SUMOylation in neurodegenerative and psychiatric disorders.
- To explore the therapeutic potential of targeting the SUMO pathway.
Main Methods:
- Literature review of SUMOylation pathway functions.
- Analysis of studies linking SUMOylation dysfunction to neurological diseases.
- Evaluation of SUMO pathway as a drug target.
Main Results:
- SUMOylation is crucial for both nuclear functions and extranuclear processes, including neuronal health.
- Defects in the SUMOylation pathway are associated with the molecular underpinnings of neurodegeneration.
- The SUMO pathway presents a promising avenue for therapeutic intervention in neurological conditions.
Conclusions:
- The SUMOylation pathway is integral to maintaining neuronal function and integrity.
- Dysregulation of SUMOylation is implicated in the pathogenesis of various neurodegenerative disorders.
- Targeting the SUMO pathway offers a potential strategy for treating neurodegenerative and psychiatric diseases.
Related Concept Videos
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:02Phosphorylation
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
01:05Proteoglycans
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...